Exicure, Inc. (XCUR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between December 18, 2019, and December 23, 2019. Exicure, Inc., a Delaware corporation and emerging growth company, reported the entry into a material definitive agreement and the subsequent closing of a public offering of its common stock.
Key Financial Metrics
The filing details a capital raise event rather than operational financial performance. Key metrics related to the transaction include:
- Shares Offered: 10,000,000 shares of Common Stock.
- Offering Price: $2.75 per share.
- Gross Proceeds: Approximately $27.5 million (before underwriting discounts and expenses).
- Underwriter Option: A 30-day option granted to underwriters to purchase up to an additional 1,500,000 shares to cover overallotments.
- Underwriter: Guggenheim Securities, LLC, as representative.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this report focuses solely on the equity offering.
Material Changes
The primary material change is the increase in the company's capital base following the closing of the Offering on December 23, 2019. The transaction was executed pursuant to a shelf registration statement (Form S-3) declared effective on July 24, 2019.
Outlook, Risks, and Management Commentary
Management announced the launch, pricing, and closing of the Offering via press releases on December 18, 19, and 23, 2019, respectively. The filing notes that the Underwriting Agreement contains customary representations, warranties, and indemnification provisions. No specific forward-looking guidance, risk factors, or contingencies regarding future operations are detailed in this specific 8-K text beyond the standard legal disclaimers regarding the agreement terms.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses.
- Confirm whether the underwriters exercised the 30-day option to purchase the additional 1,500,000 shares.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and termination provisions.
- Check subsequent filings for the use of proceeds and impact on the company's cash position.